Form 8-K - Current report:
SEC Accession No. 0001437749-25-021453
Filing Date
2025-06-27
Accepted
2025-06-27 17:27:55
Documents
16
Period of Report
2025-06-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20250627_8k.htm   iXBRL 8-K 35829
2 EXHIBIT 4.1 ex_834870.htm EX-4.1 111823
3 EXHIBIT 4.2 ex_834871.htm EX-4.2 103136
4 EXHIBIT 10.1 ex_834872.htm EX-10.1 174634
  Complete submission text file 0001437749-25-021453.txt   653651

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA wint-20250624.xsd EX-101.SCH 3579
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20250624_def.xml EX-101.DEF 11807
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20250624_lab.xml EX-101.LAB 15858
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20250624_pre.xml EX-101.PRE 12022
18 EXTRACTED XBRL INSTANCE DOCUMENT wint20250627_8k_htm.xml XML 2949
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 251088053
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)